How to Compare Veterinary Practice Offers in 2026: Net Proceeds, Structure, and Terms

Key takeaways

• Headline price is the wrong number to compare. The figure that matters is day-one cash-at-close — calculated by building a proceeds bridge for each offer: enterprise value minus debt, working capital adjustment, and holdback.
• Earnouts, rollover equity, and holdbacks are not the same as cash. Each carries its own probability of paying out. A $6M offer with 35 percent deferred often deposits less at close than a $5.5M offer with 88 percent cash upfront.
• Non-financial terms can be worth more than a multiple-point difference. Required employment duration, non-compete radius, and autonomy over clinical decisions shape your life for years after closing — they belong in the comparison.
• After-tax proceeds are the only relevant number. Goodwill gets capital-gains treatment; equipment sold above basis gets ordinary-income treatment. Two offers with the same headline price can have materially different after-tax outcomes.
• The way to generate comparable offers is a structured competitive process. A single direct offer gives one data point and no leverage. Multiple qualified buyers in a competitive window give you a market price — and the information to negotiate on every term.

I’ve watched a lot of owners get this wrong, and the pattern is consistent. Three or four offers land on the table.

The highest headline number wins. The offer gets signed, the due diligence starts, and only somewhere around week six does the owner realize the number at the top of the letter of intent is not the number that will hit their account on closing day.

The gap is never trivial. I’ve sat across from practice owners who discovered that two offers with a $400,000 difference in headline price would have deposited within $60,000 of each other after the proceeds bridge was built out.

The “winning” offer had a larger earnout and a bigger holdback. The “losing” offer was 88 percent cash at closing.

One of those is not like the other, and you don’t find out which is which until someone does the math.

Comparing veterinary practice offers properly means building a side-by-side view of three things: what you walk away with on day one, what the deferred components are realistically worth, and what life looks like under the non-financial terms. Each of those takes work.

None of it is hard. And it’s the difference between choosing well and finding out later you didn’t.

This is a sister article to our guide on who to sell your veterinary practice to and our deep-dive on veterinary practice earnouts and rollover equity. Here we focus on the mechanics of ranking offers once you have them.

What does it actually mean to compare veterinary practice offers in 2026?

To properly compare veterinary practice offers in 2026, convert each offer to a proceeds-at-close figure using the proceeds bridge formula — enterprise value minus debt, plus or minus working capital adjustment, minus holdback — then rank the deferred components separately on their probability of paying out, and score the non-financial terms that govern your post-closing life.

That’s the complete answer in two sentences. The rest of this article is the detail on how to do it.

The problem with how most offers get compared is that owners anchor on enterprise value, which is the headline price the buyer puts on the whole practice, usually calculated as a multiple of normalized EBITDA. Enterprise value is the right metric for understanding what a buyer thinks your practice is worth.

It is the wrong metric for deciding which offer puts more money in your pocket. The proceeds bridge is what converts enterprise value into the figure that actually matters.

Capstone Partners‘ April 2026 Pet Sector M&A Update reported 18 announced or completed transactions in YTD 2026 in the veterinary and pet sector combined, compared to just 8 in the prior year period, with deal momentum picking up across the board. In an active market with multiple buyers at the table, an owner who understands what each offer actually delivers has a real advantage over one who just compares multiples.

The four components of a 2026 veterinary practice offer

Every offer in the current market is built from the same four building blocks, in varying proportions. Knowing what each one is and how it behaves is the first step.

1. Cash at closing

This is the portion of the purchase price wired directly to you on closing day. It is the most certain dollar in the deal.

Whatever else the offer contains, this number is what you bank on day one.

PE-backed offers in this market commonly allocate the majority of total deal value to cash at close, with the rest split among earnout, rollover equity, and occasional seller notes. What “majority” means in practice varies by buyer, deal size, and structure.

A straightforward acquisition of a multi-doctor practice often runs 75 to 90 percent cash at close. A joint-venture structure where the seller retains a meaningful equity stake may run 60 to 70 percent.

2. Earnout

An earnout is a portion of the sale price paid after closing, only if the practice hits agreed performance targets, typically revenue or EBITDA measured over one to three years post-close. The money is not guaranteed.

It depends on post-closing performance that is partly in your hands and partly driven by decisions the new owner makes.

PE-backed offers commonly include earnouts running on multi-year EBITDA targets, per industry M&A commentary across the institutional buyer pool. The earnout creates shared incentives — you keep producing at your current level, the target gets hit, you collect.

That logic is sound, as far as it goes. The complication is that EBITDA is affected by both revenue and cost.

After closing, costs are mostly the buyer’s decision. An owner who hits every revenue target can miss the EBITDA earnout because the buyer invested in new staff, a new location, or new equipment the original targets didn’t anticipate.

Revenue-based earnouts tend to be more in the seller’s control. EBITDA-based earnouts depend on cost decisions the new owner makes.

Understanding which metric drives yours matters.

3. Rollover equity

Rollover equity means keeping a slice of ownership in the acquiring entity rather than taking all cash at close. In PE-backed deals this increasingly takes one of two forms.

The first is practice-level equity — you retain 20 to 40 percent direct ownership in your practice, structured as a joint venture, with a put/call mechanism defining the buyout date and formula price. The second is platform-level equity — you receive shares in the PE firm’s broader veterinary platform, which you hold until the firm’s eventual exit, typically 4 to 7 years out.

The upside with either form: if the platform executes well and exits at a higher multiple, your equity can deliver meaningful additional value beyond the day-one proceeds. The risk: the equity is illiquid until exit, its value depends on platform performance you don’t control, and PE firms exit on their own timelines.

Rollover equity is worth something on paper the day you sign. The actual value becomes real only when the buyer’s buyer pays for it.

4. Holdback

A holdback is a portion of the purchase price the buyer holds back for a defined period after closing, typically 12 to 24 months, to secure your representations and warranties. If no indemnification claims arise during that window, the held-back funds are wired directly to you at the end of the period.

A holdback typically represents 5 to 15 percent of the purchase price.

The holdback is the buyer’s insurance against discovering that something in the practice was different than represented. Most closings with a clean post-closing period result in the full holdback releasing without issue.

But the funds are not in your account in the meantime — and they’re not placed with a third party. The buyer holds them back against the possibility of a claim.

How to build a proceeds bridge for each offer

This is the mechanical step that turns four offers into four comparable numbers. The formula:

Day-One Cash = Enterprise Value – Debt Paid at Closing ± Working Capital Adjustment – Holdback – Rollover Equity Retained

Run it for every offer. Then list the deferred components — earnout, rollover equity — separately.

Here’s how each piece behaves in practice. Debt paid at closing includes any practice loans, equipment notes, or lines of credit the buyer pays off at close from the purchase price before wiring you the remainder. This is standard in most deals. Working capital adjustment is a smaller item — it ensures the practice has enough cash on hand to operate normally for the new owner.

The adjustment increases or decreases your proceeds based on whether your working capital at closing is above or below a negotiated target. In well-run practices this is typically a modest item, but it can surprise owners who don’t track receivables carefully.

Once you’ve run the proceeds bridge for each offer, you have four day-one cash numbers. Then you value the deferred components.

The honest way to value an earnout is to discount it for execution risk. If a buyer offers $500,000 in earnout contingent on hitting a two-year EBITDA target, and you assess a 70 percent probability of hitting the target, the probability-weighted value of that earnout is $350,000.

Every earnout in every offer deserves the same scrutiny.

Compare offers side by side — a framework

Component	Offer A	Offer B	Offer C
Enterprise value	$5.0M	$5.4M	$5.8M
Debt paid at close	($200K)	($200K)	($200K)
Working capital adj.	—	—	($50K)
Holdback (5%)	($250K)	($270K)	($290K)
Rollover retained	—	($540K)	($870K)
Day-one cash	$4.55M	$4.39M	$4.39M
Earnout (max)	—	$400K	$600K
Rollover equity (value TBD)	—	$540K	$870K
Non-compete	3 yr / 15 mi	3 yr / 20 mi	5 yr / 25 mi

The table above is illustrative — your numbers will differ — but the structure is the point. Offer C’s headline enterprise value is 16 percent higher than Offer A.

The day-one cash is nearly identical. The gap lives in deferred value that carries real execution risk.

That’s the conversation you need to have before you sign an LOI.

The non-financial terms that can swing the comparison

Once the cash comparison is clear, the non-financial terms deserve equal time. These terms don’t show up in a proceeds bridge, but they determine your experience for years after the wire clears.

Employment duration and clinical hours. Most PE-backed buyers require a post-closing employment commitment, commonly three to five years, per sources including Marti Law Group and Mahan Law, which have tracked these patterns across veterinary deal transitions. Required clinical hours per week vary, and the hours can feel materially different from what you’re used to if you’ve been running at a pace of your choosing.

Read the employment agreement alongside the LOI.

Compensation model. Many buyers move selling owners to a production-based compensation model post-closing, where your pay is tied to how much revenue you personally generate. This is a structural shift from owning the whole practice’s earnings.

It can work well for high-producers and feel constraining for owners who’ve been managing more than producing. The offer comparison should include projected first-year post-closing income under the compensation model, not just the purchase price.

Non-compete scope. The non-compete is the term that governs what you can do professionally after the agreement ends. In veterinary practice sales, a typical non-compete runs 2 to 3 years within a 10 to 25 mile radius from the practice, per guidance from Mahan Law and AVMA.

Scope matters as much as duration. A 3-year non-compete within 25 miles in a rural area may effectively prohibit any veterinary work in your region.

A 3-year non-compete within 10 miles in a dense urban market may be nearly meaningless. Evaluate scope in the context of your geography and your plans post-close.

Clinical autonomy. Different buyers integrate practices differently. Some leave clinical decision-making entirely to the medical director on site.

Others centralize formulary, staffing decisions, or pricing. The LOI rarely addresses this in detail — you find out in conversations with the buyer’s integration team and in references from practice owners who’ve transacted with them before.

The regulatory layer: what 2026 adds to the comparison in some markets

In New York, veterinary practice acquisitions entered a new regulatory environment in 2026 that sellers in that state need to factor into any offer timeline. New York’s Assembly introduced legislation (AB 9042) that would require acquiring entities to submit written notice and supporting documentation to the Department of Agriculture and Markets no later than 14 days after signing, prior to consummation, with the Attorney General’s office then conducting a public-interest review. Per Holland & Knight’s September 2025 analysis, the review period could run up to 90 days.

The practical implication for offer comparisons in New York: a buyer with robust diligence files and experience navigating regulatory review may be structurally preferable to a buyer who has never closed a deal in the state. This is a non-financial term with financial consequences if a deal stalls or falls through during review.

If you’re in New York, it belongs in your comparison.

We cover the broader regulatory backdrop for vet practice acquisitions in our veterinary practice consolidators piece.

How to value a competitive offer vs a direct offer

The single most effective thing you can do to generate offers worth comparing is to have more than one.

A direct offer from a single buyer — where one party approaches you with a term sheet, you negotiate it, and you close — gives you one data point. You have no idea whether the number you’re looking at reflects what your practice would clear in a market.

You have no leverage over price, structure, or non-compete scope. And the buyer knows it.

A structured competitive process changes every one of those dynamics. Per Capstone Partners’ 2026 sector research, strategic buyer activity climbed to 10 transactions in YTD 2026 versus just 3 in YTD 2025, and buyer appetite across the PE-backed group has also rebounded from the slower 2025 environment.

That means there are real buyers competing for good practices right now. The difference between receiving one of them and receiving three is the difference between a direct offer and a market price.

I’ve seen the same practice generate materially different enterprise values across buyers who each had a slightly different view of the upside. None of the variation was in the practice itself.

All of it was in the competitive pressure that forced each buyer to sharpen their number. When buyers know they are competing, the LOI terms shift — on price, on earnout structure, and often on non-financial terms that a seller would never have negotiated successfully in a one-buyer process.

This is what the Elite Selling System is built for. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

The compression that creates forces each qualified buyer to put their best structure forward, knowing they are being compared side by side. You get the framework this article describes — but filled in with real competing numbers, not one offer you’re trying to evaluate in a vacuum.

The gap between a single direct offer and a competitive-process outcome is not theoretical. It is consistent.

And nearly all of it flows into the goodwill line — the most tax-favored component of your price. We cover how private equity prices vet practices in detail if you want to understand what the competitive range looks like right now.

What to do before you sign any LOI

The letter of intent (LOI) is typically 2 to 10 pages and is generally non-binding on price — but it sets the anchor for every subsequent negotiation. Whatever isn’t in the LOI rarely gets added in the definitive agreement, and what is in it is very hard to remove.

A few things belong in your comparison before you sign anything.

Ask for a proceeds bridge. Ask every buyer to provide a written schedule walking from enterprise value to day-one cash. The buyers who resist doing this are telling you something.

The buyers who hand it over cleanly are demonstrating they understand what you actually need to see.

Model your post-closing income. If the offer includes a production-based employment agreement, estimate your first-year compensation under the model. For many practice owners, post-closing W-2 income is a material part of the total deal economics in years one through three.

Run the after-tax comparison. Work with your CPA to calculate after-tax proceeds for each offer. The goodwill component of the price is generally taxed as a long-term capital gain, while tangible assets sold above their basis are generally taxed as ordinary income.

Two offers with the same headline price and a different allocation between goodwill and equipment can produce meaningfully different after-tax outcomes. This is not a footnote — on a multi-million-dollar transaction, the difference can reach six figures.

We cover the full tax picture in our guide on who to sell your veterinary practice to.

Reference-check the buyer. Every major PE-backed group and strategic buyer has acquired other practices. The owners who transacted with them are the best source of information on what integration actually looks like, how the employment agreement felt in year two, and whether the earnout calculation was done in good faith.

Ask for references. Talk to them.

The right offer isn’t always the highest headline

There’s a version of this where the proceeds bridge comes out nearly equal across three offers and the difference is entirely in the non-financial terms. That happens more often than people expect.

When it does, the offer that wins is the one where you trust the buyer, the employment agreement feels workable, and the non-compete won’t wall you off from the profession you’ve built.

A larger practice with strong EBITDA, clean financials, and a real competitive process behind it tends to attract buyers who compete on all three dimensions — price, structure, and terms. That’s the environment where you find out what your practice is actually worth in 2026, across the full offer, not just the headline.

Our guide on how to valuate a veterinary practice covers the baseline before any offers arrive.

---

You can get a free, confidential practice value estimate whenever it makes sense.

When you’re ready to compare real offers instead of hypothetical ones, the first step is knowing what your practice is worth and who the right buyers are. That’s what we build for each owner who comes through our process — a clear picture of value, a vetted buyer pool, and the structure that generates competing offers you can actually compare.

We work on a success-based engagement. No upfront fees, no retainer.

We get paid only when a deal closes, and only out of the value created above what you would have realized on your own. If a competitive process doesn’t deliver a result worth acting on, you’ve lost nothing.

---

Frequently asked questions

How do I compare veterinary practice offers side by side in 2026?

To compare veterinary practice offers in 2026, convert each offer to a net-proceeds-at-close figure using the proceeds bridge formula: enterprise value minus debt, plus or minus working capital adjustment, minus any holdback the buyer retains. Then compare the deferred components — earnouts, rollover equity, and seller notes — separately on their probability of paying out.

Finally, compare non-financial terms: employment duration, non-compete scope, and autonomy over clinical decisions. A higher headline number with a large earnout often deposits less cash on day one than a slightly lower headline with an 85 percent cash-at-close structure.

---

What is a proceeds bridge in a vet practice sale?

A proceeds bridge is a schedule that walks from the headline enterprise value down to the actual dollars wired to the seller at close. The bridge subtracts any debt or liabilities paid off at closing, adjusts for working capital above or below a target, and subtracts any holdback the buyer retains.

The result is the day-one cash-at-close. Rollover equity and earnouts are then shown separately as contingent future value.

---

What is an earnout in a veterinary practice deal?

An earnout is a portion of the sale price paid after closing, only if the practice hits agreed performance targets such as revenue or EBITDA over a defined period, commonly one to three years after closing. Money tied to an earnout is not guaranteed — it depends on post-closing performance that is partly in the seller’s control and partly in the buyer’s hands.

PE-backed offers commonly include earnouts on multi-year EBITDA targets.

---

What is rollover equity in a veterinary practice sale?

Rollover equity means keeping a slice of ownership in the acquiring entity instead of taking all cash at close. In PE-backed deals it commonly means retaining 20 to 40 percent of the practice as equity in the new combined entity, with a contractual formula that governs the eventual buyout.

The upside is participating in platform appreciation if the PE firm exits at a higher multiple. The risk is that the equity value depends on the buyer’s platform performance and the timing of their eventual exit.

---

What does a holdback mean in a veterinary practice sale?

A holdback is a portion of the purchase price the buyer holds back for a defined period after closing, typically 12 to 24 months, to secure the seller’s representations and warranties. If no indemnification claims arise during that window, the held-back funds are wired directly to the seller at the end of the period.

A holdback is retained by the buyer — funds are not placed with a third party. It typically represents 5 to 15 percent of the purchase price.

---

What non-financial terms should I compare across veterinary practice offers?

The most important non-financial terms to compare across offers are: employment duration and required clinical hours after closing, non-compete scope (duration and geographic radius), compensation structure and whether it is production-based or salary, autonomy over clinical decisions and staffing, and the buyer’s integration approach for branding and operations. These terms determine your day-to-day life for years after closing — a better headline number with unfavorable employment terms can be the wrong choice.

---

How much of a veterinary practice sale is cash at closing?

In PE-backed offers the majority of total deal value is typically allocated to cash at close, with the rest split among earnout, rollover equity, and occasional seller notes. The exact split varies by buyer and deal size.

A direct single-buyer offer may deliver 85 to 90 percent cash at close with a modest holdback. A deal with a joint-venture structure or large earnout component may deliver 60 to 70 percent in day-one cash even though the headline enterprise value is higher.

---

Does a higher offer price always mean more money for the seller?

No. A higher headline enterprise value does not always mean more money in the seller’s account.

The net-proceeds-at-close depends on how much of the price is paid in cash at closing versus deferred through earnouts, rollover equity, and holdbacks. A $6 million offer with 65 percent cash at close delivers $3.9 million on day one.

A $5.5 million offer with 88 percent cash at close delivers $4.84 million. Comparing offers without a proceeds bridge is comparing the wrong number.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion; VSOs Under Increasing Pressure.” 2025. octus.com

Legal and regulatory analysis

3. Holland & Knight. “Up Next: Vet Clinic Acquisitions Targeted for Review and Approval in New York.” September 2025. hklaw.com
4. Holland & Knight. “Charting a Path Forward in 2026: Year-End Healthcare Antitrust Report.” December 2025. hklaw.com
5. Mahan Law. “Letter of Intent: Binding or Non-Binding.” mahanlaw.com
6. Mahan Law. “Rollover Equity Attorney for Veterinarians.” mahanlaw.com
7. Mahan Law. “Non-Compete and Non-Solicitation Clauses in Veterinary Contracts.” June 2025. mahanlaw.com

Veterinary practice operations, deal structure, and profession data

8. AVMA. “The Shifting Landscape of Noncompete Agreements.” avma.org
9. AVMA. “NVA Splits into Two Businesses, May Go Public in Next Few Years.” avma.org
10. Today’s Veterinary Business. “Seal the Deal.” todaysveterinarybusiness.com
11. Mandelbaum Barrett PC. “How to Retain Your Veterinarians and Staff When Selling Your Veterinary Practice.” mblawfirm.com

Public company disclosures and buyer information

12. Mission Pet Health. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” July 2025. missionpethealth.com
13. JAB Holding Company. Press release: NVA Acquisition. jabholco.com